LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US5147661046
LIFECORE BIOMEDICAL, INC. \DE\ financials
| Fiscal year | 2025 | 2026 |
|---|---|---|
| Revenue | 128.87 m USD | 129.46 m USD |
| Gross profit | 40.30 m USD | 40.61 m USD |
| Operating income | -17.25 m USD | -1.26 m USD |
| EBIT | -16.84 m USD | – |
| Net income | -38.72 m USD | -30.79 m USD |
| Diluted EPS – continuing operations | -1.27 USD | -0.82 USD |
Full history since 1996, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About LIFECORE BIOMEDICAL, INC. \DE\
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications. In addition, it offers product development services, including analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and materials production for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
More stocks
- Xxentria Technology Materials Co Ltd (8942.TWO)
- Taiwan Taxi Co Ltd (2640.TWO)
- American Outdoor Brands, Inc. (AOUT)
- XINYUREN ORD A (SHH) EQSW Exp: (688573.SS)
- Asia Polymer Corp (1308.TW)
- Daishin Balance No.8 Special Purpose Acquisition Co. Ltd (336570.KQ)
- Caswell Inc (6416.TW)
- Jmicron Technology (4925.TWO)
- USANA HEALTH SCIENCES INC (USNA)
- SC Asset Corporation Public Company Limited (SC.BK)
- OCTAVE SPECIALTY GROUP INC (OSG)
- Summarecon Agung Tbk (SMRA.JK)
Not investment advice. All data without warranty, price as of 10.11.2026. Details in the risk notice.